Current therapy of choice for cutaneous lymphomas: Complementary to the Japanese Dermatological Association/Japanese Skin Cancer Society guidelines.
The first Japanese edition of guidelines for management of cutaneous lymphoma was published jointly in 2009 by the Japanese Dermatological Association (JDA) and the Japanese Skin Cancer Society (JSCS) - Lymphoma Study Group; the guidelines were revised in 2011, and published in English in 2013. The JDA/JSCS guidelines are unique because they describe information and management practices for lymphomas specific to Asia, such as adult T-cell leukemia/lymphoma and extranodal natural killer/T-cell lymphoma, nasal type. In the present article, we have highlighted the essential points of management for cutaneous lymphomas in Asia. In order to complement the guidelines, we have added further information and our clinical experience of some currently available agents for cutaneous lymphomas in Japan.
Departments of Dermatology, Okayama University Graduate, School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Keiji
K
Iwatsuki
Toshihisa
T
Hamada
D006801:Humans; D016393:Lymphoma, B-Cell / Q000628:therapy; D016399:Lymphoma, T-Cell / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012878:Skin Neoplasms / Q000628:therapy*
adult T-cell leukemia/lymphoma; extranodal natural killer/T-cell lymphoma; guideline; interferon-γ; mycosis fungoides; vorinostat